Free medical cannabis laboratory assessments offered in an effort to help decrease opioid use and associated fatalities.
Washington, DC – Across the nation, opioid-related deaths and fatalities are decreasing in states that have medical cannabis programs, but the benefits are limited due to a lack of accurately labeled and tested cannabis products. Patient Focused Certification (PFC), a project of Americans for Safe Access, announced today that it will begin offering free assessments and certification services for cannabis testing laboratories to help increase the number of safe and standardized medical products, in an effort to help combat the opioid epidemic.
Americans for Safe Access Submits Comments at Trump’s first official meeting to address drug addiction, opioid abuse
WASHINGTON, DC — Today, June 16th, Governor Chris Christie (NJ) will chair the first meeting of the President’s commision on Drug Addiction and Combating Opioid abuse. Christie is joined on the Commission by Gov Charlie Baker (MA), Gov. Roy Cooper (NC), Rep. Patrick Kennedy and Professor Bertha Madras, Ph.D.
Compassionate Access, Research Expansion, and Respect the States Bipartisan (CARERS) Act Introduced with Senators Booker, Lee, Paul, Murkowski, Gillibrand, and Franken
WASHINGTON, DC — Today, Senators Cory Booker (D-NJ), Senator Mike Lee (R-UT), Senator Kirsten Gillibrand (D-NY), Senator Rand Paul (R-KY), Senator Al Franken (D-MN), and Senator Lisa Murkowski (R-AK) introduced the most comprehensive medical cannabis bill in the United States Senate to date. Several elected officials argue that CARERS, which has already garnered bipartisan support in the House and Senate, could be a solution to the nation’s opioid epidemic. The bill would also protect users of medical cannabis who comply with state laws from unwarranted federal prosecution and expand the opportunity for medical and scientific research on the uses and effects of medical cannabis.
Americans for Safe Access’s Patient Focused Certification standards for medical marijuana accepted as foundational recommendations
Last week, global standards organization ASTM International and the American Herbal Products Association (AHPA) announced that they will develop standards for the cannabis industry. Under the agreement, ASTM International will coordinate standards development activities for the cannabis industry, while AHPA will gain recognition for its technical contributions and regulatory recommendations. The AHPA standards are the basis of the Patient Focused Certification (PFC) program that is used internationally to assess regulatory compliance at medical cannabis operations, and to educate the medical cannabis industry and program administrators.
Baltimore, MD — On Friday, June 2nd, physicians, cannabis industry professionals, and members of Americans for Safe Access will rally to protect patient access to medical cannabis throughout Maryland State. After more than four years since its legalization, medical cannabis patients are now months away from accessing prescribed medicinal cannabis in Maryland, unless Baltimore City Circuit Court decides to halt licensing of medical cannabis growers.
NASHVILLE, TENNESSEE -- Americans for Safe Access (ASA), the nation’s largest patient-focused medical cannabis advocacy organization, is pleased to announce new membership opportunities for medical cannabis patient advocates in Tennessee.
Last week, Maryland regulators issued the first license to grow medical cannabis in Maryland to ForwardGro, a company with a 1-acre greenhouse located in Anne Arundel County. This decision comes more than four years after Maryland first approved a medical cannabis program.
WASHINGTON DC -- Earlier today, Attorney General Jeff Sessions told reporters that “I think medical marijuana has been hyped, maybe too much.”
In reaction to Sessions’ comments, Steph Sherer, executive director of Americans for Safe Access, a national nonprofit dedicated to ensuring safe and legal access to medical cannabis for therapeutic use and research, issued the following statement:
More than 85% of the U.S. population live in states with medical cannabis laws, and over 2 million Americans are benefiting from its use. These laws address the healthcare needs of patients who benefit from cannabis-based treatments, often where conventional medications have failed. Patient populations include people living with or treating cancer, HIV/AIDS, Multiple Sclerosis, Crohn’s Disease, Amyotrophic Lateral Sclerosis (ALS), epilepsy, severe childhood epilepsy disorders such as Dravet Syndrome, Post-Traumatic Stress Disorder (PTSD), chronic pain, and a myriad of other conditions.
Statements like these from the Attorney General are factually inaccurate - in January, the National Academies of Sciences, Medicine, and Engineering released a report that reviewed over 10,000 research articles, which states there is conclusive, moderate, and substantial evidence for benefits of cannabis in several conditions. Sessions needs to stop spreading unfounded, unscientific theories about medical marijuana and take the time to actually meet the millions of Americans that are benefitting from its use before making comments about it being over-hyped.
Americans for Safe Access Urges Members of Congress to Stop Using False Information About Marijuana
Washington, DC — Today, Americans for Safe Access, a national nonprofit dedicated to ensuring safe and legal access to medical cannabis for therapeutic use and research, sent a memo to Congress informing members that the Drug Enforcement Administration (DEA) has removed false information about cannabis from its website after months of public pressure. The memo explains;
Forty-four states now allow patients under their physician's care to use medical cannabis (marijuana) in some form, and the majority of the rest of the states are discussing medical cannabis in their current legislative sessions. In addition, three cannabis related budget amendments and four bills have been introduced so far in the 115th Congress.
We know that you rely on the Drug Enforcement Administration (DEA) to provide current and accurate information when you are making decisions about cannabis policy. Americans for Safe Access (ASA) has prepared this memo to inform you about four important changes in the DEA’s positions on medical cannabis that could have an impact on your policy making decisions this session.
View the memo here: http://www.safeaccessnow.org/iqa_memo